If you’re considering a GLP-1 weight-loss injection in Glendale or the greater Phoenix area, you’ve probably hit the same question everyone asks: semaglutide or tirzepatide — which one is better? Both are FDA-approved, both can produce dramatic results, and both sit at the center of the biggest shift in medical weight loss in a generation. But they are not the same medication, and the “right” choice depends on more than a single number.
At Total Medical & Wellness, we prescribe both — and we choose between them based on your goals, history, and how your body responds. Here’s an honest, up-to-date (2026) breakdown.
The quick answer
In head-to-head research, tirzepatide produces more average weight loss than standard-dose semaglutide. But semaglutide has a longer track record, more dosing flexibility, and — as of 2026 — a new higher-dose version that closes much of the gap. Neither is universally “best.” The better question is which one fits your situation — and that’s a medical decision, not a coin flip.
What’s actually the difference?
Semaglutide (the active ingredient in Ozempic® and Wegovy®) is a GLP-1 receptor agonist. It mimics a gut hormone that curbs appetite, slows stomach emptying, and helps regulate blood sugar.
Tirzepatide (the active ingredient in Mounjaro® and Zepbound®) is a dual GIP/GLP-1 receptor agonist — it works on two gut-hormone pathways instead of one. That second mechanism appears to be why, on average, it drives more weight loss.
Head-to-head: how much weight can you lose?
The landmark SURMOUNT-5 trial compared the two drugs directly over 72 weeks:
| Measure | Tirzepatide | Semaglutide (2.4 mg) |
|---|---|---|
| Avg. weight lost (72 wks) | −20.2% | −13.7% |
| Average pounds lost | ~50 lbs | ~33 lbs |
| Mechanism | Dual GIP + GLP-1 | GLP-1 only |
| Brand names | Mounjaro®, Zepbound® | Ozempic®, Wegovy® |
On paper, tirzepatide wins on raw weight loss. But “average” is doing a lot of work in that sentence — individual results vary widely, and the standard-dose comparison doesn’t tell the whole 2026 story.
The 2026 update that changes the math
In April 2026, the FDA approved a higher-dose semaglutide — 7.2 mg (Wegovy® HD). In the STEP UP trial, this dose produced 18.7% average weight loss versus 15.6% at the standard 2.4 mg dose — narrowing the gap with tirzepatide (20.2%) to about a point and a half.
The tradeoff: the 7.2 mg dose introduced a side effect not seen at standard doses — dysesthesia (abnormal skin sensations such as burning or tingling), reported in roughly 23% of patients versus 6% at the lower dose. That’s exactly the kind of risk-versus-benefit call best made with a provider, not on your own.
Side effects & tolerability
Both medications share a similar side-effect profile, mostly gastrointestinal: nausea, constipation, diarrhea, and reduced appetite — especially when starting or increasing the dose. For most people these ease over time. The key to minimizing them is a slow, supervised dose titration: starting low and stepping up only as your body adjusts. Many patients tolerate one drug better than the other, which is often the deciding factor in practice.
Cost, access & the right fit
Pricing, insurance coverage, and supply differ between the two and change frequently. Beyond cost, the right choice depends on your starting point, your goal, your medical history, how you tolerate the medication, and whether you have a related condition such as type 2 diabetes. A higher number on a trial chart doesn’t automatically make a drug right for you.
How we choose for you at Total Medical & Wellness
This is where a medically guided program matters. Our weight-loss programs in Glendale aren’t a one-size-fits-all online subscription. We start with lab work and a full health review, match you to the medication that fits your goals and tolerance, titrate your dose carefully, and monitor your progress — adjusting as we go. If one medication isn’t the right fit, we change course. You can learn more about our medical weight loss program in Glendale.
Frequently asked questions
Is tirzepatide better than semaglutide?
On average, tirzepatide produces more weight loss in head-to-head studies. But “better” depends on your goals, tolerance, cost, and medical history — and 2026’s higher-dose semaglutide narrows the difference. The right choice is individual and best made with a provider.
Are semaglutide and tirzepatide the same as Ozempic and Mounjaro?
Semaglutide is the active ingredient in Ozempic® (for diabetes) and Wegovy® (for weight loss). Tirzepatide is the active ingredient in Mounjaro® (for diabetes) and Zepbound® (for weight loss).
How much weight can I expect to lose?
In trials, average loss was about 20% of body weight on tirzepatide and 14–19% on semaglutide depending on dose. Real-world results vary based on your starting point, dose, diet, activity, and consistency. Your provider will set realistic expectations for you.
How are the injections taken?
Both are self-administered as a small once-weekly injection under the skin — typically in the abdomen, thigh, or upper arm. We teach you exactly how at your visit.
Do I have to take it forever?
Not necessarily, but weight regain is common if the medication is stopped abruptly without a plan. We focus on sustainable habits and a long-term strategy — which may include maintenance dosing, tapering, or transitioning off — tailored to you.
Are these medications safe?
They are FDA-approved and have been studied extensively, but they aren’t right for everyone. That’s why we review your full medical history and monitor you throughout — to keep treatment both effective and safe.
Stop Guessing Which Weight-Loss Shot Is Right for You
Semaglutide or tirzepatide, the right choice isn’t about the bigger number on a study — it’s about matching the medication to your body, your goals, and your history.
If you want a real answer from a provider who knows your case — not a one-size-fits-all online subscription — it’s time for an evaluation.
Book your weight-loss consultation at Total Medical & Wellness in Glendale →
Or call us directly at (623) 259-6900.
Serving Glendale, Peoria, Surprise, and the greater Phoenix West Valley.
This article is for educational purposes and does not constitute medical advice. Individual results vary. Medication decisions should be made with a licensed provider who knows your history. A clinical evaluation is required to determine candidacy.
